Trump Suggests Reimbursing Venezuela Oil Investments; New Products at CES | Bloomberg Brief 1/6/2025

Watch on YouTube ↗  |  January 06, 2026 at 14:51  |  42:53  |  Bloomberg Markets
Speakers
Vonnie Quinn — Anchor, Bloomberg
Valerie Tytel — Reporter, Bloomberg
Ben Luckock — Global Head of Oil, Trafigura
Tom Mackenzie — Anchor, Bloomberg
Sitara Sundar — Global Investment Specialist, J.P. Morgan Private Bank
Neil Campling — Tech/TMT Analyst

Summary

Bloomberg Brief covers Venezuela's political transition after Maduro's ouster and Trump's suggestion that the US may reimburse oil investments in Venezuela. Trafigura's Ben Luckock says the oil market is oversupplied and sees low prices in the prompt and medium term, while JPMorgan's Sitara Sundar sees broadening earnings growth supporting financials, healthcare, and core private equity. CES coverage focuses on Nvidia's Vera Rubin, AMD's AI demand, and Intel's 18A notebook platform. Market movers include Vistra's gas plant acquisition, Adidas's downgrade, Novo Nordisk's weight-loss pill launch, and copper's tariff-driven rally.

  • Venezuela swears in Delcy Rodriguez as acting president; Maduro pleads not guilty in US court.
  • Trump suggests possible US reimbursement for Venezuela oil investments; oil executives are set to meet.
  • Trafigura's Ben Luckock sees oil oversupplied and low prices near-to-medium term.
  • JPMorgan's Sitara Sundar favors AI capex beneficiaries, financials, healthcare, and core private equity.
  • CES: Nvidia says Vera Rubin is in production for H2; AMD sees strong AI demand; Intel shows 18A notebooks.
  • Market movers include Vistra's gas plant deal, Microchip's sales forecast, Adidas downgrade, and Novo Nordisk's pill launch.
  • Copper rallies on tariff front-running; iron ore lags on glut.
  • Macro focus is on Fed speak, PMI data, and Friday's jobs report.
Ideas
Vonnie Quinn Anchor, Bloomberg 1:39
Iron ore glut keeps prices weak.
Base metals are rallying, but iron ore is the only major one left out because there is a glut, so it is not participating in the broader commodity move.
Valerie Tytel Reporter, Bloomberg 2:04
Vistra adds gas for AI data centers.
Vistra is paying about $4 billion for ten natural gas-fired power plants to catch up in the AI race; natural gas generation is seen as a key answer for data centers that need round-the-clock power.
Valerie Tytel Reporter, Bloomberg 2:33
Microchip sees strong bookings demand.
Microchip Technology had a decent boost in third-quarter sales and its CEO cited strong bookings demand for the December quarter, lifting the shares premarket.
Valerie Tytel Reporter, Bloomberg 2:52
Adidas faces end of casualization trend.
Adidas received a double downgrade from Bank of America, which downgraded many sportswear brands citing the 20-year casualization trend largely coming to an end; Adidas shares fell over 6% in Germany.
Ben Luckock Global Head of Oil, Trafigura 13:41
Oil oversupplied; crude prices stay low.
The oil market is oversupplied; Venezuela stability removes a potential supply disruption, Russia-Ukraine peace could return Russian barrels, and even Iran risk is unlikely to drive prices significantly higher, so he expects low oil prices in the prompt and medium term.
Tom Mackenzie Anchor, Bloomberg 17:45
NVIDIA Vera Rubin demand remains strong.
NVIDIA pre-announced details around its Vera Rubin accelerator because customer demand and use-case complexity are so strong; the chip is in production and will ship in the second half, demand shows no letup, and China H200 licensing could open a $50 billion market.
Tom Mackenzie Anchor, Bloomberg 18:03
AMD sees strong early AI demand.
AMD CEO Lisa Su echoed Nvidia's strong demand commentary and said AMD is still in the early stages of its AI story, supporting the competitive AI chip growth outlook.
Valerie Tytel Reporter, Bloomberg 23:27
Core Scientific pivots to digital infrastructure.
Core Scientific received a BTIG upgrade; it was one of the largest listed bitcoin miners and is now becoming a key player in digital infrastructure by building out eight data centers.
Valerie Tytel Reporter, Bloomberg 23:53
Novo weight-loss pill launch drives volumes.
Novo Nordisk will begin selling its newly approved weight-loss pill across the US in 70,000 pharmacies, and the stock is rising on excitement about potential volumes and margins.
Sitara Sundar Global Investment Specialist, J.P. Morgan Private Bank 25:04
AI capex supports semis, industrials, utilities.
Artificial intelligence continues to bolster technology through semiconductors, and the capex cycle is still strong, which should also support infrastructure plays including industrials and utilities.
Sitara Sundar Global Investment Specialist, J.P. Morgan Private Bank 25:48
Financials benefit from steepening curve, capital markets.
Financials are coming back into the forefront, helped not only by a steepening yield curve but also by increased capital market activity as earnings growth broadens.
Sitara Sundar Global Investment Specialist, J.P. Morgan Private Bank 26:01
Healthcare revival driven by M&A, innovation.
Health care is reviving after years in the doldrums, with a pickup in M&A activity and drug innovation as patent cliffs become more pressing over the next few years.
Sitara Sundar Global Investment Specialist, J.P. Morgan Private Bank 28:22
Core private equity set to outperform.
She is increasingly more constructive on core private equity after three years of underperformance; broadening earnings growth, opening IPO/M&A windows, resilient growth, easing financial conditions, and median private-company earnings growth of 11.5% should support the asset class.
Sitara Sundar Global Investment Specialist, J.P. Morgan Private Bank 29:46
AI application layer accessible via private markets.
Within private markets, AI is moving from infrastructure into the application layer; 95% of software companies are private, and the application layer could be a $6 trillion opportunity by 2030 that is mainly accessible through private markets.
Sitara Sundar Global Investment Specialist, J.P. Morgan Private Bank 30:16
Small/mid-cap biotech are pharma M&A targets.
About 70% of drug innovation happens through M&A, with big pharma buying small and mid-cap biotech companies; this makes small and mid-cap biotech M&A targets a key healthcare innovation theme.
Sitara Sundar Global Investment Specialist, J.P. Morgan Private Bank 30:31
Security theme spans defense, energy transition.
The security theme spans energy transition, supply chain security, and defense technology, with significant innovation occurring in venture capital and growth within that space.
Neil Campling Tech/TMT Analyst 37:22
AI adoption layer supports Big Tech ROI.
CES is showing AI move from concepts into practical devices and products; Samsung expects Gemini usage to grow from 400 million to 800 million smartphones, which helps justify the investment and ROI curve for big tech companies.
Neil Campling Tech/TMT Analyst 39:20
Intel 18A platform key to comeback.
Intel is showing off its new 18A platform for notebooks and laptops; it is the first product on that platform and key to Intel's comeback, with positive timing after past missed innovation and launch dates, though user adoption remains uncertain.
Vonnie Quinn Anchor, Bloomberg 42:35
Copper rally driven by tariff front-running.
Copper continues to run higher as the US front-loads purchases in case there are more tariffs later in the year, supporting the base metals rally.
Up Next

This Bloomberg Markets video, published January 06, 2026, features Vonnie Quinn, Valerie Tytel, Ben Luckock, Tom Mackenzie, Sitara Sundar, Neil Campling discussing Iron Ore, VST, MCHP, ADDYY, WTI, NVDA, AMD, CORZ, NVO, SMH, XLI, UTILITIES, XLF, XLV, Core private equity, Private-market software/application layer, Small/mid-cap biotech, Defense technology, ICLN, Supply chain security, XLK, INTC, COPPER. 19 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Vonnie Quinn, Valerie Tytel, Ben Luckock, Tom Mackenzie, Sitara Sundar, Neil Campling  · Tickers: Iron Ore, VST, MCHP, ADDYY, WTI, NVDA, AMD, CORZ, NVO, SMH, XLI, UTILITIES, XLF, XLV, Core private equity, Private-market software/application layer, Small/mid-cap biotech, Defense technology, ICLN, Supply chain security, XLK, INTC, COPPER